Pe rețetă 📍 ES

RINGO 0,120 MG/0,015 MG CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL EFG

Analogs of RINGO 0,120 MG/0,015 MG CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL EFG

Find cheaper analogs and generic equivalents for RINGO 0,120 MG/0,015 MG CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL EFG.

Buy now on Amazon Search results on Amazon.ca — as an Amazon Associate we earn from qualifying purchases.

Ingredients

Substanță activă: etonogestrel, ethinylestradiol

Prezentare produs

About RINGO 0,120 MG/0,015 MG CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL EFG

RINGO 0,120 MG/0,015 MG CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL EFG is a combined oral contraceptive system designed for continuous use. The product delivers a steady release of etonogestrel and ethinylestradiol through a vaginal ring that is worn for 24 hours and replaced daily. This mode of administration provides a convenient alternative to daily pills while maintaining effective hormone levels. The formulation is intended for use by women who require reliable contraception and who prefer a discreet, low-maintenance method. The ring is inserted into the vagina and remains in place for the entire 24‑hour period, after which it is removed and a new ring is inserted. The product is manufactured under strict quality controls to ensure consistent hormone release and safety.

Key Benefits & Uses

Provides continuous contraception with a simple daily routine.
Maintains stable hormone levels to reduce breakthrough bleeding.
Offers a discreet and user‑friendly alternative to oral tablets.

Active Ingredient & Action

The active components are etonogestrel, a progestin that prevents ovulation, and ethinylestradiol, an estrogen that stabilizes the endometrial lining. Together, they inhibit the release of luteinizing hormone and follicle‑stimulating hormone, thereby preventing ovulation and thickening cervical mucus to impede sperm penetration.

Important Notes

RINGO 0,120 MG/0,015 MG CADA 24 HORAS, SISTEMA DE LIBERACION VAGINAL EFG should be used according to the prescribing information. It is not suitable for individuals with certain medical conditions such as active liver disease, thromboembolic disorders, or a history of hormone‑sensitive cancers. Pregnant women should discontinue use immediately and consult a healthcare professional. The product should be stored in a cool, dry place and kept out of reach of children. For further guidance, consult a qualified healthcare provider before initiating therapy.